3,4-EtMC

What is 3,4-EtMC?

3,4-EtMC (3,4-EthyleneMethCathinone) is a chemical analog of 3-MMC and 4-MMC. This means that, due to its structural similarity and similar charge distribution, it can dock onto the same receptors in the brain and thus produce comparable biological effects.

3,4-EtMC belongs to the cathinone group of substances, a class of psychoactive substances originally extracted from the khat plant. This plant has been traditionally chewed in East Africa and the Arabian Peninsula for centuries to take advantage of its stimulating and euphoric effects. In these regions, chewing khat leaves has a cultural significance comparable to drinking coffee in European countries.

In recent years, the use of cathinones has also spread in Western cultures. This has resulted in numerous synthetic derivatives, including the novel 3,4-EtMC. Cathinones are similar in structure and effect to amphetamines and have become known under names such as “legal highs” or “bath salts”. These names arose partly due to the extreme behavioral changes observed in some users. These circumstances have contributed to the stigmatization of cathinones in modern society. In addition, many cathinones were falsely sold as MDMA on the black market, leading to misinterpretation and abuse.

Since there are only a few scientific studies on 3,4-EtMC and the substance is considered a research chemical, most of the available information is based on field reports.

Structurally, 3,4-EtMC is similar to both methylone (MDMC) and methcathinone (4-MMC). It differs mainly in the replacement of the methylenedioxy bridge with an ethylene bridge. As it is a novel substance and research results are limited, much of the information on 3,4-EtMC is based on field reports and similarities to 3-MMC, 4-MMC and methylone.

Effect profile of 3,4-EtMC

The spectrum of effects of 3,4-EtMC is often described by users as similar to that of MDMA. This similarity is unsurprising, as similar cathinones that were on the market before 3,4-EtMC appeared were often sold as MDMA. 3,4-EtMC, like MDMA, acts on the monoaminergic systems in the brain, particularly neurotransmitters such as dopamine, serotonin and noradrenaline. These systems are crucial for the mood-enhancing, stimulating and empathogenic effects that occur with both MDMA and 3,4-EtMC.

Entactogenic and empathogenic effect: 3,4-EtMC is described as entactogenic, which means that it increases the intensity of one's own emotions. At the same time, it has empathogenic properties, which increases the feeling of connection with other people. Users often report a calm, relaxed euphoria accompanied by a subtle feeling of warmth in the chest and abdomen.

Stimulating effects: In addition to the entactogenic effects, users report increased energy, increased sexual arousal, urge to exercise and motivation. Compared to MDMA, some find the effect less euphoric but more stimulating. Some compare the effect to a mixture of low doses of MDMA and cocaine.

Dose dependence: The effect of 3,4-EtMC is highly dose-dependent and is described as slightly less potent compared to an equivalent dose of MDMA. Despite the stimulant effects, short-term memory remains largely unaffected and thoughts remain clear. Interestingly, some users report that the “comedown” is less unpleasant with 3,4-EtMC than with MDMA, with some even stating that the “coming down” causes no negative effects at all.

Effects at high doses: At very high doses, the stimulating short-term effects come to the fore. This can lead to an increased heart rate and a rise in blood pressure. Other symptoms include tremors, uncontrolled eye twitching and muscle and jaw cramps.

Duration and effects of 3,4-EtMC

3,4-EtMC, like other cathinones, can be consumed in a variety of ways: orally, nasally, by smoking, injection or rectal ingestion. In this context, we focus on oral and nasal use, as these methods are the most common and allow better control over dosage and effects. Other methods of consumption carry significant risks that can affect the safety and well-being of the user.

Oral administration is the preferred method for many users as it offers a slower but more stable onset of action. This method makes it possible to better control the effect and minimize side effects such as mucosal damage. When taken orally, the effect usually sets in after 30 to 60 minutes and lasts for around 3 to 4 hours.

Nasal application, on the other hand, leads to a faster onset of action, usually within 5 to 20 minutes. However, the duration of effect is shorter, around 1 to 2 hours. A significant risk with this method is the increased “craving”, i.e. the intense desire to consume more of the substance. This craving can be significantly stronger than with other empathogenic substances, which increases the risk of developing dependence. Particular caution is therefore required with nasal consumption and this method should be avoided wherever possible.

Dosage and safety

Regardless of the method chosen, it is essential to dose the substance precisely. A precision scale is essential to avoid overdosing. For oral use, it is advisable to fill the substance into gelatine capsules to protect the mucous membranes and ensure a controlled release.

Extended recommendations

Additional notes

• Caution with cravings: When used nasally, the craving for a new dose is much more pronounced, which increases the risk of excessive use and possible damage to health.
• Safe to use: Use a precision scale to measure the substance precisely and fill the measured amount into gelatine capsules to ensure protection of the mucous membranes.
  

BACK TO OVERVIEW